Drug Store News - Merck - Reporter’s Notebook: Branded News - approval gained for Singulair for hay fever relief in adults and children - Brief Article
The FDA also approved this month Merck’s Singulair for the relief of symptoms of hay fever in adults and children as young as 2 years of age.
Unlike antihistamines, Singulair treats seasonal allergies by blocking leukotrienes, substances produced by certain cells in the human body, instead of blocking histamine. Leukotrienes trigger a number of effects that have been connected with symptoms of both asthma and allergic rhinitis.
Related Results
Popular prescription drugs
Gilead Names John W. Madigan to Board and Merck Announces US Label Change for…
Positive new data for Merck & Co’s Singulair.
For allergic rhinitis, two drugs found equivalent.(Pulmonary Medicine)(Drug o…
Drug patent expiration list. (Rx/Generic Drugs).(Brief Article)
Singulair is available in tablet form for adults (10 mg) and as a cherry chewable tablet (4 mg or 5 mg) for children ages 2 to 14. Singulair also is approved to help control asthma.
COPYRIGHT 2003 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2008 Gale, Cengage Learning
